HIGHLIGHTS
- who: Sayuri Sekimitsu et al. from the Tufts University School of Medicine, Boston, MA, United States of America, Department of have published the research: Interaction of background genetic risk, psychotropic medications, and primary angle closure glaucoma in the UK Biobank, in the Journal: PLOS ONE of January/11,/2022
- what: The authors demonstrate the utility of a genome-wide polygenic risk score (PRS) in identifying and risk-stratifying subjects with PACG and investigate the association between PACG genetic burden and exposure to psychotropic medications on prevalent angle closure. The authors demonstrate an important relationship where . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.